Compare Citius Pharmaceuticals Inc (CTXR) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Riot Platforms Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.77 (market cap $20.01M), while Riot Platforms Inc trades at $20.35 (market cap $7.59B). The key difference: Riot Platforms Inc is far larger — about 379.3× Citius Pharmaceuticals Inc's market cap, and Riot Platforms Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | RIOT | |
|---|---|---|
Market Cap | $20.01M | $7.59B |
Sector | Health | Technology |
52-Week High | $1.82 | $28.67 |
52-Week Low | $0.48 | $11.33 |
Enterprise Value | $16.23M | $8.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTXR trades at $0.7554, up 11.58% today, with a bullish technical signal from moving averages. The company reported a net loss of $37.43M for 2025, with a negative net income margin of -823.34%, but shows revenue growth from its LYMPHIR launch. Recent news highlights commercial expansion and positive clinical data presentations at ASCO 2026.
The outlook is speculative; analyst consensus is strongly bullish (83.3% Buy), but high cash burn and consistent earnings misses pose significant risks. Investment potential hinges on successful commercialization of LYMPHIR to achieve profitability.
RIOT Platforms trades at $20.835, up 7.4% on news of a transformative $9.1 billion AI infrastructure deal with Anthropic. Despite bearish technical signals and consecutive quarterly losses, the stock shows strong momentum driven by the company's strategic pivot from bitcoin mining to data center operations. Analyst sentiment remains overwhelmingly positive with 94% buy ratings and a $33.40 consensus price target, representing significant upside potential.
The outlook hinges on successful execution of the AI infrastructure strategy, though substantial risks persist including negative cash flow, widening losses, and competitive pressures. Investors face a high-risk, high-reward scenario where the massive Anthropic deal could drive long-term value if operational challenges are overcome.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
